(NASDAQ: DXCM), the global leader in glucose biosensing, announced today the FDA has cleared Dexcom Smart Basal, the first and only CGM-integrated basal insulin dosing optimizer designed for adults ...

DexCom receives FDA clearance for DexCom Smart Basal titration software module, which optimizes basal insulin dose in type 2 ...

Lugano Diamonds & Jewelry Inc. ("Lugano" or the "Company"), a designer, manufacturer, and retailer of high-end jewelry, today announced that the Company and certain of its affiliates have voluntarily ...

A new store design, though, will be found at Winnipeg’s newest London Drugs location, opening on Nov. 21 in CF Polo Park. The ...

Dexcom (NSDQ:DXCM) announced today that the FDA cleared its Smart Basal CGM-integrated basal insulin dosing optimizer.

Dexcom’s “Smart Basal” has received FDA clearance for people with type 2 diabetes using long-acting insulin. The feature will ...

In honor of National Diabetes Awareness Month, DAV (Disabled American Veterans) announced today a new strategic partnership ...

Dexcom announced the Dexcom G7 15 Day Continuous Glucose Monitoring System for people over the age of 18 with diabetes will ...

Dexcom has obtained an FDA clearance for its basal insulin dosing optimizing program, designed for adults with Type 2 diabetes using its continuous glucose monitors.  | Dexcom said Smart Basal is the ...

Dexcom Inc. received U.S. FDA clearance for its Smart Basal CGM-integrated basal insulin dosing optimizer. Designed for adults with type 2 diabetes using glargine U-100 long-acting insulin therapy, ...

Fill your party plate with poultry or fish, greens, low-glycemic fruits such as apples or grapes, nuts, and other ...

Why Is DexCom a Good Business? Founded in 1999 and receiving its first FDA approval in 2006, DexCom (NASDAQ:DXCM) develops ...